Confirmation of guideline‐defined hepatitis C screening strategies within the ‘Check‐Up35+’ examination in the primary care setting

Author:

Petroff David1,Wolffram Ingmar2,Bätz Olaf3,Jedrysiak Katrin3,Kramer Jan3,Berg Thomas4,Wiegand Johannes4ORCID

Affiliation:

1. Clinical Trial Centre University of Leipzig Leipzig Germany

2. General Practitioner Paderborn Germany

3. LADR Laboratory Group Dr. Kramer & Colleagues Geesthacht Germany

4. Division of Hepatology, Department of Medicine II Leipzig University Medical Center Leipzig Germany

Abstract

AbstractBackground and AimsScreening strategies for undiagnosed infections are fundamental for hepatitis C virus (HCV) elimination. We previously investigated HCV prevalence and screening strategies in an urban primary care setting. IV drug abuse, blood transfusion before 1992, immigration, or elevated ALT were identified as risk factors in a post hoc analysis and diagnosed 83% of unknown HCV‐RNA‐positive cases by screening only 26% of the population.We aimed to validate prospectively the proposed screening algorithm in two independent urban and rural cohorts and to analyse for potential differences.MethodsAnti‐HCV and ALT were included in a routine check‐up together with a questionnaire covering risk factors. HCV‐RNA was analysed in anti‐HCV‐positive individuals.ResultsIn urban and rural areas, 4323 and 9321 individuals were recruited. The anti‐HCV prevalence was 0.56% and 0.49%, and 0.1% of patients were HCV‐RNA‐positive in both regions. Fifty‐two anti‐HCV positive patients including eight HCV‐RNA‐positive cases were unaware of the infection (number needed to screen to detect one unknown anti‐HCV‐positive individual: 262). At least one of the three aforementioned risk factors or elevated serum ALT was present in 3000 patients (22%). Restricting HCV screening to only those with risk factors, 52% and 75% of all anti‐HCV and HCV‐RNA‐positive undiagnosed patients were identified (number needed to screen: 111).ConclusionsWe confirm prospectively the efficiency of a risk‐based HCV screening. The risk‐based algorithm should be evaluated in other countries with similarly low HCV prevalence as in Germany to achieve WHO HCV elimination goals.

Funder

AbbVie Deutschland

Gilead Sciences

Merck Sharp and Dohme

Publisher

Wiley

Subject

Hepatology

Reference26 articles.

1. Global timing of hepatitis C virus elimination in high‐income countries

2. Bundesministerium für Gesundheit Bundesministerium für wirtschaftliche Zusammenarbeit und Entwicklung. Strategie zur Eindämmung von HIV Hepatitis B und C und anderen sexuell übertragbaren Infektionen.BIS 2030 – bedarfsorientiert integriert sektorübergreifend. Beschluss des Bundeskabinetts vom 6 April 2016.2016;1–28.

3. The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

4. Updated epidemiology of hepatitis C virus infections and implications for hepatitis C virus elimination in Germany

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3